Q3 2021 Financial Results Conference Call

November 4, 2021- 2:00 pm PT

Upcoming Events

Nov 4, 2021 • 2:00pm PDT

Inogen 2021 Third Quarter Financial Results

Latest Presentation

Investor Presentation

Latest Financial Results

Q2 2021

Quarter Ended Jun 30, 2021

$101.6M Total Revenue of $101.6 million
49.6% Total gross margin of 49.6%

For complete information regarding our financials, see our periodic filings

Latest Annual Meeting

May 10, 2021 • 10:00am PDT

Inogen 2021 Annual Meeting of Shareholders

Sign up for Email Alerts

Give Me Alerts

Stock Information

Inogen, Inc.

About Inogen

Inogen is a medical technology company offering innovative respiratory products for use in the homecare setting.

View Company Profile

2020 Revenue Breakdown

2019 Revenue Breakdown

Products

Inogen One G5® product image

Inogen One G5®

  • 6 flow settings
  • 4.7 pounds
  • Battery life up to 13 hours
  • Technology clinically validated for 24/7 use
  • Meets FAA requirements
Inogen One G4® product image

Inogen One G4®

  • 3 flow settings
  • 2.8 pounds
  • Battery life up to 5 hours
  • Meets FAA requirements
  • Technology clinically validated for 24/7 use
Inogen At Home® product image

Inogen At Home®

  • 5 liters per minute, continuous flow
  • Only 18 pounds
  • Extremely quiet
  • Energy-efficient
  • Only 100W on Flow Setting 2
Inogen TAV® product image

Inogen TAV®

  • Tidal Assist Ventilator
  • High flow and pressure compared to traditional oxygen therapy
  • Study results demonstrate over 2x increase in average exercise endurance

A Team Built for Success

Our leadership team is focused on strengthening the Inogen brand via expanding awareness of our innovative solutions as well as growing across our consumer and business sales channels.